ArticleScientific reports2025
Unveiling the nanotoxicology of snake venoms through functional and biochemical characterization of extracellular vesicles from Naja naja and Daboia russelii.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Snake venom is a complex biochemical arsenal that exerts multifaceted effects on host physiology, primarily targeting the hemostatic, cellular, and metabolic systems. Recent attention has turned to venom-derived extracellular vesicles (EVs) as active carriers of toxin components. The current study comparatively evaluates the hematological and enzymatic effects of crude venoms and EVs from Naja naja and Daboia russelii across key physiological parameters: prothrombin time (PT), activated partial thromboplastin time (aPTT), red blood cell hemolysis, and purinergic enzyme activity (ATPase and ADPase). Both venoms and their EVs caused dose-dependent alterations in coagulation, with EVs significantly prolonging aPTT and PT, indicating intrinsic and extrinsic pathway inhibition. Hemolysis assays revealed sex-specific erythrocyte susceptibility, with higher rates observed in female samples. Additionally, venom-derived EVs modulated ATPase and ADPase activity, interfering with cellular energy metabolism and thromboregulation. Our findings establish venom EVs as potent functional units that replicate and amplify native venom toxicity. These results underscore the importance of targeting EV-associated toxins in antivenom development and highlight the evolving complexity of venom systems biology. This study broadens our understanding of venom pathophysiology and identifies novel diagnostic and therapeutic avenues against snakebite envenomation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.